搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Prochlorococcus marinus Ribosome-binding factor A (rbfA) CSB-YP381892PZG
CSB-EP381892PZG
CSB-BP381892PZG
CSB-MP381892PZG
CSB-EP381892PZG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus Photosystem I assembly protein ycf3 (ycf3) CSB-YP381893PZG
CSB-EP381893PZG
CSB-BP381893PZG
CSB-MP381893PZG
CSB-EP381893PZG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus Tryptophan synthase beta chain (trpB) CSB-YP381894PZG
CSB-EP381894PZG
CSB-BP381894PZG
CSB-MP381894PZG
CSB-EP381894PZG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus Probable rRNA maturation factor (P9515_02111) CSB-YP381895PZG
CSB-EP381895PZG
CSB-BP381895PZG
CSB-MP381895PZG
CSB-EP381895PZG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus UDP-N-acetylglucosamine--N-acetylmuramyl- (pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase CSB-YP381896PZG
CSB-EP381896PZG
CSB-BP381896PZG
CSB-MP381896PZG
CSB-EP381896PZG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus 50S ribosomal protein L7/L12 (rplL) CSB-YP381897PZG
CSB-EP381897PZG
CSB-BP381897PZG
CSB-MP381897PZG
CSB-EP381897PZG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus Enolase (eno) CSB-YP381898PZG
CSB-EP381898PZG
CSB-BP381898PZG
CSB-MP381898PZG
CSB-EP381898PZG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus Chorismate synthase (aroC) CSB-YP381899PZG
CSB-EP381899PZG
CSB-BP381899PZG
CSB-MP381899PZG
CSB-EP381899PZG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus Phosphoglucosamine mutase (glmM) CSB-YP381900PZG
CSB-EP381900PZG
CSB-BP381900PZG
CSB-MP381900PZG
CSB-EP381900PZG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus Protein psbN (psbN), partial CSB-YP381901PZG
CSB-EP381901PZG
CSB-BP381901PZG
CSB-MP381901PZG
CSB-EP381901PZG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus Sugar fermentation stimulation protein homolog (sfsA) CSB-YP381902PZG
CSB-EP381902PZG
CSB-BP381902PZG
CSB-MP381902PZG
CSB-EP381902PZG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus Orotate phosphoribosyltransferase (pyrE) CSB-YP381903PZG
CSB-EP381903PZG
CSB-BP381903PZG
CSB-MP381903PZG
CSB-EP381903PZG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus NAD (P)H-quinone oxidoreductase subunit K CSB-YP381904PZG
CSB-EP381904PZG
CSB-BP381904PZG
CSB-MP381904PZG
CSB-EP381904PZG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus Cytochrome b559 subunit alpha (psbE), partial CSB-YP381905PZG1
CSB-EP381905PZG1
CSB-BP381905PZG1
CSB-MP381905PZG1
CSB-EP381905PZG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus Photosystem II reaction center protein L (psbL), partial CSB-YP381906PZG
CSB-EP381906PZG
CSB-BP381906PZG
CSB-MP381906PZG
CSB-EP381906PZG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus Cytochrome b6-f complex subunit 4 (petD), partial CSB-YP381907PZG1
CSB-EP381907PZG1
CSB-BP381907PZG1
CSB-MP381907PZG1
CSB-EP381907PZG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus GTPase Der (der) CSB-YP381908PZG
CSB-EP381908PZG
CSB-BP381908PZG
CSB-MP381908PZG
CSB-EP381908PZG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus Elongation factor 4 (lepA), partial CSB-YP381909PZG
CSB-EP381909PZG
CSB-BP381909PZG
CSB-MP381909PZG
CSB-EP381909PZG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus NAD (P)H-quinone oxidoreductase subunit 2, partial CSB-YP381910PZG
CSB-EP381910PZG
CSB-BP381910PZG
CSB-MP381910PZG
CSB-EP381910PZG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus Prolipoprotein diacylglyceryl transferase (lgt), partial CSB-YP381911PZG1
CSB-EP381911PZG1
CSB-BP381911PZG1
CSB-MP381911PZG1
CSB-EP381911PZG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>